Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: J Child Neurol. 2014 Aug 13;30(7):842–849. doi: 10.1177/0883073814544364

Table 2.

Patient characteristics of those with radiographically detected ICM

Patient Gender Cancer Type Age at Radiation Therapy Radiation Dose (cGy) Radiation Field ICM location Interval of f/u MRI (year) Time to ICM detection (years) Age at ICM detection (years)
1 male MB 6 6100 whole brain left frontal periventricular 1 1 7
2 female MB 7 6055 posterior fossa left parietal 1 6 13
3 female PA 7 5800 posterior fossa left inferior temporal 1 12 20
4* male PA 8 5580 right frontal right frontoparietal 1 19 28
5* male MG 8 5400 left temporal left temporal lobe 2 13 21
6 male AA 10 5940 whole brain bilateral thalami 1 6 16
7 male BL 11 2400 frontal frontal subcortical 0 14 26
8 male MEC 14 5760 parotid right frontal lobe 1 4 19
9 male PA 15 5580 whole brain right periventricular 0 24 39
10* male PA 16 6600 right temporal right temporal parietal 2 11 28
*

These patients received surgical resection for symptomatic ICM (Patient 4: seizures and headache; Patient 5: headache; Patient 10: L sided numbness, weakness and facial droop)

presented as years after cranial radiation therapy.

AA = Anaplastic astrocytoma, BL = Burkitt's lymphoma, PA = pilocytic astrocytoma, MB = medulloblastoma, MEC = mucoid epidermal carcinoma, MG = mixed germinoma